Clinical Trial Update: A Long Term Extension Study to Assess the Safety of TB006 in Participants With Alzheimer's Disease [Phase 2]

View source ↗

Summary

The long-term extension study evaluating TB006 for safety in Alzheimer's disease participants has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• TB006

Snippet

Sponsor: TrueBinding, Inc. | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED